A risk-benefit assessment of abciximab in angioplastyKLEIMAN, N. S.Drug safety. 1999, Vol 20, Num 1, pp 43-57, issn 0114-5916Article

Description of patients undergoing high risk angioplasty : analyses of various databasesKLEIMAN, N. S.European heart journal. 1995, Vol 16, Num NOV, pp 30-35, issn 0195-668X, SUPLConference Paper

Goals of thrombolytic therapyKLEIMAN, N. S.The American journal of cardiology. 1991, Vol 68, Num 12, pp 67C-71C, issn 0002-9149Article

Percutaneous transluminal coronary angioplasty : is what we see what we get ?KLEIMAN, N. S; RAIZNER, A. E; ROBERRTS, R et al.Journal of the American College of Cardiology. 1990, Vol 16, Num 3, pp 576-577, issn 0735-1097, 2 p.Article

Platelet glycoprotein IIb/IIIa antagonists : What are the relevant issues concerning their pharmacology and clinical use?SCARBOROUGH, R. M; KLEIMAN, N. S; PHILLIPS, D. R et al.Circulation (New York, N.Y.). 1999, Vol 100, Num 4, pp 437-444, issn 0009-7322Article

Interobserver variability in grading of coronary arterial narrowings using the American college of cardiology/American heart association grading criteriaKLEIMAN, N. S; RODRIGUEZ, A. R; RAIZNER, A. E et al.The American journal of cardiology. 1992, Vol 69, Num 4, pp 413-415, issn 0002-9149Article

Patients with acute coronary syndromes without persistent st elevation undergoing percutaneous coronary intervention benefit most from early intervention with protection by a glycoprotein IIb/IIIa receptor blocker. EditorialRONNER, E; BOERSMA, E; CALIFF, R. M et al.European heart journal. 2002, Vol 23, Num 3, pp 194-197, issn 0195-668X, 12 p.Article

Coronary flow reserve may predict myocardial recovery after myocardial infarction in patients with TIMI grade 3 flowMAZUR, W; BITAR, J. N; LECHIN, M et al.The American heart journal. 1998, Vol 136, Num 2, pp 335-344, issn 0002-8703Article

Diabetes mellitus, glycoprotein IIb/IIIa blockade, and heparin : Evidence for a complex interaction in a multicenter trialKLEIMAN, N. S; LINCOFF, A. M; KEREIAKES, D. J et al.Circulation (New York, N.Y.). 1998, Vol 97, Num 19, pp 1912-1920, issn 0009-7322Article

Role of myocardial contrast echocardiography during nonsurgical septal reduction therapy for hypertrophic obstructive cardiomyopathyNAGUEH, S. F; LAKKIS, N. M; SPENCER, W. H et al.Journal of the American College of Cardiology. 1998, Vol 32, Num 1, pp 225-229, issn 0735-1097Article

Relation between inhibition of platelet aggregation and clinical outcomesHARRINGTON, R. A; KLEIMAN, N. S; GRANGER, C. B et al.The American heart journal. 1998, Vol 136, Num 4, pp S43-S50, issn 0002-8703, 2Conference Paper

Differential dose-response to oral xemilofiban after antecedent intravenous abciximab : Administration for complex coronary interventionKEREIAKES, D. J; RUNYON, J. P; KLEIMAN, N. S et al.Circulation (New York, N.Y.). 1996, Vol 94, Num 5, pp 906-910, issn 0009-7322Article

Coronary angioplasty, atherectomy and bypass surgery in cardiac transplant recipientsHALLE, A. A; DISCIASCIO, G; WRAY, R. B et al.Journal of the American College of Cardiology. 1995, Vol 26, Num 1, pp 120-128, issn 0735-1097Article

Mechanisms of early death despite thrombolytic therapy : experience from the thrombolysis in myocardial infarction phase II (TIMI II) studyKLEIMAN, N. S; TERRIN, M; MUELLER, H et al.Journal of the American College of Cardiology. 1992, Vol 19, Num 6, pp 1129-1135, issn 0735-1097Article

Effectiveness of videotaped dietary instruction for patients hospitalized with cardiovascular diseaseBRANDAO, J. J; BRADEMAN, G. M; MOORE, C. E et al.Journal of the American Dietetic Association. 1992, Vol 92, Num 10, pp 1268-1270, issn 0002-8223Article

Inability of isolated soluble interleukin-2 receptor levels to predict biopsy rejection scores after heart transplantationYOUNG, J. B; WINDSOR, N. T; SMART, F. W et al.Transplantation. 1991, Vol 51, Num 3, pp 636-641, issn 0041-1337, 6 p.Article

Comparison of quantitative coronary angiography to visual estimates of lesion severity pre and post PTCAGOLDBERG, R. K; KLEIMAN, N. S; MINOR, S. T et al.The American heart journal. 1990, Vol 119, Num 1, pp 178-184, issn 0002-8703Article

Prinzmetal's angina during 5-fluorouracil chemotherapyKLEIMAN, N. S; LEHANE, D. E; GEYER, C. E. JR et al.The American journal of medicine. 1987, Vol 82, pp 586-588, issn 0002-9343Article

Impact of preprocedural white blood cell count on long term mortality after percutaneous coronary intervention: insights from the EPIC, EPILOG, and EPISTENT trialsGURM, H. S; BHATT, D. L; LINCOFF, A. M et al.Heart (London 1996). 2003, Vol 89, Num 10, pp 1200-1204, issn 1355-6037, 5 p.Article

Relation of coagulation parameters to patency and recurrent ischemia in the Thrombolysis in Myocardial Infarction (TIMI) Phase II TrialTRACY, R. P; KLEIMAN, N. S; SOPKO, G et al.The American heart journal. 1998, Vol 135, Num 1, pp 29-37, issn 0002-8703Article

Long-term protection from myocardial ischemic events in a randomized trial of brief integrin β₃ blockade with percutaneous coronary interventionTOPOL, E. J; FERGUSON, J. J; CALIFF, R. M et al.JAMA, the journal of the American Medical Association. 1997, Vol 278, Num 6, pp 479-484, issn 0098-7484Article

Cardiac troponin T levels for risk stratification in acute myocardial ischemiaMAGNUS OHMAN, E; ARMSTRONG, P. W; CALIFF, R. M et al.The New England journal of medicine. 1996, Vol 335, Num 18, pp 1333-1341, issn 0028-4793Article

Differential inhibition of platelet aggregation induced by adenosine diphosphate or a thrombin receptor-activating peptide in patients treated with bolus chimeric 7E3 Fab : implications for inhibition of the internal pool of GPIIb/IIIa receptorsKLEIMAN, N. S; RAIZNER, A. E; JORDAN, R et al.Journal of the American College of Cardiology. 1995, Vol 26, Num 7, pp 1665-1671, issn 0735-1097Article

Immediate and reversible platelet inhibition after intravenous administration of a peptide glycoprotein IIb/IIIa inhibitor during percutaneous coronary interventionHARRINGTON, R. A; KLEIMAN, N. S; GREENBERG, C. S et al.The American journal of cardiology. 1995, Vol 76, Num 17, pp 1222-1227, issn 0002-9149Article

A pilot trial of recombinant desulfatohirudin compared with heparin in conjunction with tissue-type plasminogen activator and aspirin for acute myocardial infarction : results of the thrombolysis in myocardial infarction (TIMI) 5 trialCANNON, C. P; MCCABE, C. H; SHARAF, B. L et al.Journal of the American College of Cardiology. 1994, Vol 23, Num 5, pp 993-1003, issn 0735-1097Article